Article
Metabolic reprogramming to optimise breast cancer treatment
2019-01-01
Abstract excerpt
Breast cancer is the most common cancer in women worldwide, accounting for a quarter of all female cancer cases. Despite improvements in early diagnosis and treatment, the mortality rate for breast cancer has remained stubbornly high, with some subtypes unresponsive to current treatments. One reason for this is the metabolic heterogeneity of breast cancer, with some sub-types having poor treatment options. Breast...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7aa6d18b-860f-5457-9b00-f8078afdd0c9
- DOI
- 10.15126/thesis.00853293